Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katherine Falcone"'
Autor:
Candice Felman, Zhong-Qian Li, Natascha Svensson, Rachel R. Radwan, Sara Gannon, Catherine Peacock, Natalya Benina, Julianna Young, Christian Fermer, Savitha Raju, Sharee D. Jones, Katherine Falcone, Anders Öhrvik, Diana L. Dickson
Publikováno v:
Cancer Research. 76:437-437
Human epididymis protein 4 (HE4), a member of Whey acidic four-disulfide core protein (WFDC) family, was demonstrated as one of the most useful biomarkers for ovarian cancer (HellstrÖm I, et al. 2003; Drapkin R, et al. 2005; Moore RG, et al. 2007).T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6ea0d8393a847881a428f896c91e3fc
https://doi.org/10.1158/1538-7445.am2016-437
https://doi.org/10.1158/1538-7445.am2016-437
Abstract 5299: Monitoring of ovarian cancer recurrence and progression via Lumipulse G CA125II assay
Autor:
Rachel R. Radwan, Katherine Falcone, Zhong-Qian Li, John Le, Julianna T. Young, Diana L. Dickson, Savitha Raju, Sara Gannon, Catherine Peacock, Sharee D. Jones
Publikováno v:
Cancer Research. 75:5299-5299
CA125 is useful for monitoring the course of ovarian cancer. The correlation between CA125 serum levels and the course of the disease was reported to be 87% (Kenemans, 1993). Persistently rising CA125 levels may be associated with malignant disease a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9fc205179d674279c609ebc6628d2d5
https://doi.org/10.1158/1538-7445.am2015-5299
https://doi.org/10.1158/1538-7445.am2015-5299
Autor:
Zivjena Vucetic, Maryellen Fegely, Diana L. Dickson, Maria Hellman, Zhong-Qian Li, Rachel R. Radwan, Kuanglin He, Christian Fermer, Savitha Raju, Katherine Falcone, Grady Barnes, Timothy R. Kettlety, Richard G. Moore
Publikováno v:
Journal of Clinical Oncology. 31:5563-5563
5563 Background: Urinary HE4 has been reported as a promising biomarker for ovarian cancer (OC). In the current study, a large validation was performed to evaluate urinary HE4 as a biomarker for the stratification of OC from benign pelvic masses. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a28132ab0253da6f98b4f5b111b58b1b
https://doi.org/10.1200/jco.2013.31.15_suppl.5563
https://doi.org/10.1200/jco.2013.31.15_suppl.5563
Autor:
Savitha Raju, Katherine Falcone, Timothy R. Kettlety, Zhong-Qian Li, Kuanglin He, Maryellen Fegely, Rachel R. Radwan, Robert J. Smalley, Curtis L. Glover
Publikováno v:
Journal of Clinical Oncology. 30:e15565-e15565
e15565 Background: CYFRA 21-1 is a known lung cancer biomarker. In subjects with ovarian cancer (OC) versus those with benign gynecological diseases, serum CYFRA 21-1 was reported sensitivities (SN) of 44% and 41% at specificity (SP) of 95% for OC de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18406226369f7b68631ad084ffb2a716
https://doi.org/10.1200/jco.2012.30.15_suppl.e15565
https://doi.org/10.1200/jco.2012.30.15_suppl.e15565
Autor:
Zhong-Qian Li, Maryellen Fegely, Timothy R. Kettlety, Kuanglin He, Robert J. Smalley, Rachel R. Radwan, Savitha Raju, Katherine Falcone, Curtis L. Glover
Publikováno v:
Cancer Research. 72:3574-3574
CYFRA 21-1 is a known lung cancer biomarker. In subjects with ovarian cancer (N = 159) and those with benign gynecological diseases (N = 53), serum CYFRA 21-1 reported a sensitivity (SN) of 44% and a specificity (SP) of 95% for ovarian cancer detecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::501bbce41d98c771c395e37ab711340b
https://doi.org/10.1158/1538-7445.am2012-3574
https://doi.org/10.1158/1538-7445.am2012-3574
Autor:
Timothy R. Kettlety, Grady Barnes, Julie Polkowski, Rebecca Simamora, Rachel R. Radwan, Richard G. Moore, Savitha Raju, Katherine Falcone, Zhong-Qian Li
Publikováno v:
Cancer Research. 71:LB-451
Human epididymis protein 4 (HE4) has been shown to be a promising serum biomarker for epithelial ovarian cancer (EOC). Recently, Hellstrom et al. reported the detection of HE4 in urine as a biomarker for ovarian neoplasms (Cancer Lett.2010;296:43–8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6552322c8c9a171efd9adb60ea341933
https://doi.org/10.1158/1538-7445.am2011-lb-451
https://doi.org/10.1158/1538-7445.am2011-lb-451
Autor:
R. Simamora, Zhong-Qian Li, J. Young, B. Acon, Rachel R. Radwan, Diana L. Dickson, B. Burkhart, Timothy R. Kettlety, Curtis L. Glover, J. Polkowski, Savitha Raju, A. Vasko, Grady Barnes, L. Zhu, D. Kenney, Katherine Falcone
Publikováno v:
Cancer Research. 70:4653-4653
Human epididymis protein 4 (HE4) is a whey acidic four-disulfide core protein. Serum HE4 has been shown to be a promising biomarker for epithelial ovarian cancer (EOC) with manual HE4 EIA assays. The ARCHITECT system is one of the major automated for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32355bc1f6e1f95b590852ab1b29921f
https://doi.org/10.1158/1538-7445.am10-4653
https://doi.org/10.1158/1538-7445.am10-4653